BioAtla, Inc.
BCAB · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$69,776 | -$123,462 | -$106,482 | -$95,402 |
| Dep. & Amort. | $925 | $1,221 | $1,199 | $1,330 |
| Deferred Tax | $0 | $0 | $0 | -$686 |
| Stock-Based Comp. | $8,921 | $13,544 | $14,563 | $25,117 |
| Change in WC | -$11,199 | $4,680 | $287 | $7,424 |
| Other Non-Cash | -$807 | $2 | $13 | $3 |
| Operating Cash Flow | -$71,936 | -$104,015 | -$90,420 | -$62,214 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$98 | -$268 | -$924 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $3 | $0 |
| Investing Cash Flow | $0 | -$98 | -$265 | -$924 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $9,215 | $336 | $61,682 | $70,994 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $296 | -$259 | -$469 | -$1,482 |
| Financing Cash Flow | $9,511 | $77 | $61,213 | $69,512 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$62,425 | -$104,036 | -$29,472 | $6,374 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $111,471 | $215,507 | $244,979 | $238,605 |
| End Cash | $49,046 | $111,471 | $215,507 | $244,979 |
| Free Cash Flow | -$71,936 | -$104,113 | -$90,688 | -$63,138 |